VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 132 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,430,000 | -13.4% | 105,900 | -28.1% | 0.14% | -15.2% |
| Q2 2018 | $2,806,000 | -36.5% | 147,300 | -43.8% | 0.16% | -41.8% |
| Q1 2018 | $4,418,000 | -24.2% | 262,200 | -31.6% | 0.28% | -9.6% |
| Q4 2017 | $5,827,000 | -8.1% | 383,400 | +8.2% | 0.31% | -8.2% |
| Q3 2017 | $6,343,000 | +32.6% | 354,400 | +20.8% | 0.34% | +15.3% |
| Q2 2017 | $4,782,000 | +72.1% | 293,400 | +47.8% | 0.30% | +67.6% |
| Q1 2017 | $2,779,000 | +265.7% | 198,500 | +316.1% | 0.18% | +183.9% |
| Q4 2016 | $760,000 | +25.0% | 47,700 | -12.3% | 0.06% | +8.8% |
| Q2 2016 | $608,000 | -34.3% | 54,400 | -52.7% | 0.06% | -77.0% |
| Q2 2013 | $926,000 | – | 115,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |